Richard S Geary sold $6.7M of Ionis Pharmaceuticals (IONS)

Executed Oct 31 2025, disclosed Nov 3 2025, 3 days later.

Value, as filed

$6.7M

89,249 sh across 3 lots

Executed

Oct 31 2025

the trade date, as filed

Disclosed

Nov 3 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RG Richard S Geary EVP, Chief Development Officer profile →

Richard S Geary (EVP, Chief Development Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $6.7M of IONS (89,249 sh across 3 lots, as filed), executed Oct 31 2025.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Richard S Geary in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $2.5M
33,038 sh across 2 lots
Exec Nov 6 2025
Filed Nov 7 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $3.8M
57,900 sh × $65.24
Exec Sep 30 2025
Filed Oct 1 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $504K
10,000 sh × $50.37
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $429K
10,000 sh × $42.86
Exec Aug 5 2025
Filed Aug 6 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $232K
7,072 sh × $32.86
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET